Table 2 Overview of the examined treatment options
From: Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
Established therapies | Physical Therapy |
Pain control (opoids, NSARs, steroids, antidepressants) | |
Renal Transplantation | |
Based on case reports | Extracorporal photopheresis |
Plasmapheresis | |
UV- A1 therapy | |
High dose iv. Immunoglobulines | |
Imatinib Mesylate | |
Rabamycine | |
| Â | Pentoxifylline |
Anecdotal | Topical dovonex |
Cytoxan | |
Thalidomide | |
Immunosuppression via Steroids |